Sorafenib in the treatment of thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sorafenib in the treatment of thyroid cancer

Published:2015-07-07 Issue:8 Volume:15 Page:863-874
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Ferrari Silvia Martina,Politti Ugo,Spisni Roberto,Materazzi Gabriele,Baldini Enke,Ulisse Salvatore,Miccoli Paolo,Antonelli Alessandro,Fallahi Poupak

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.2015.1064770

Reference92 articles.

1. Incidence of thyroid cancer in England by ethnic group, 2001–2007

2. Thyroid Cancer Incidence among Active Duty U.S. Military Personnel, 1990–2004

3. Cancer de la thyroïde après exposition aux rayonnements ionisants

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer;Expert Opinion on Pharmacotherapy;2024-08-12

2. Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series;European Thyroid Journal;2023-07-26

3. Update on Molecular Diagnostics in Thyroid Pathology: A Review;Genes;2023-06-22

4. Molecular features of aggressive thyroid cancer;Frontiers in Oncology;2022-12-20

5. Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach;Frontiers in Oncology;2022-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3